About Marapharm

Officers and Directors
 

Linda Sampson, Director and CEO

Linda Sampson brings a dynamic energy, a wealth of talent, and a multi-layered business expertise to the Company. She is a business start-up professional, with a history of ground-up to successful ventures.  An accomplished sales professional, marketer, designer, developer, with international experience, she brings superior business branding skills and internal administrative talents to Marapharm.

Corey Klassen, Chief Financial Officer and Director

Mr. Klassen, as a resident of Saskatoon, Sask., has a strong financing background and more than 20 years' of business development management experience for major Canadian financial institutions, mortgage brokerage firms and publicly traded companies. Mr. Klassen is the owner of a successful mortgage brokerage and was recently recognized as one of the top 75 brokers in Canada by CMP Magazine.

As a director and advisor for various junior companies over the past several years, his financial background and expertise provides considerable experience with public companies where he has been instrumental in numerous capital raising ventures inclusive of medical marijuana companies.

Yari Nieken, Director, Corporate Secretary and Audit Committee

Yari has a wide range of public company and capital market experience. He is the founder and president of Foremost Capital Inc., an exempt market dealer. He is a consultant for public companies with Paradigm Shift Consulting, has served on boards of several public companies and was an investment advisor at Union Securities and remains a registrant in good standing in British Columbia, Alberta and Ontario. Yari holds an MBA from the Sydney Graduate School of Management and a BA from the University of British Columbia.

Business and Industry Advisors

Several business strategists, negotiators, deal facilitators, security lawyers and financial professionals consult with Marapharm Ventures Inc. throughout the sourcing, merger, acquisition and management processes of our business expansion and diversified ventures.

Marapharm Management Information

From the beginning, the success path (business plan) for Marapharm included a 3 step plan for the evolvement of management and board members; development, growth, operations.

Marapharm has created and developed it's business model and relationships and has been aggressive with growth. Marapharm is entering the operations part of it's plan. Accordingly new and or additional board members and management personal with skill sets for this advanced stage in Marapharm's success will stand for respective positions at the annual general meeting to be held in August or September, 2016.

 

MDM on CSE:
thecse.ca
| MRPHF on OTCQB:
otcmarkets.com
| 2M0 (zero) on FSE:
boerse-frankfurt.de